Physician profile
Astrid Mondaca
NPI 1326336306
$4,644.27
in general payments reported to CMS, 2019-2025
45 companies · $632 in 2025
The $632 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $628 · 2021: $909 · 2022: $717 · 2023: $876 · 2024: $384 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.81 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $368.85 | 2021-2025 | |
| Hologic Sales and Service, LLC | $365.07 | 2019-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Astellas Pharma US INC | $260.48 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $219.85 | 2021-2025 | Zurzuvae |
| Myovant Sciences INC. | $219.40 | 2021-2022 | |
| Daiichi Sankyo INC. | $211.80 | 2019-2023 | Injectafer |
| Avion Pharmaceuticals | $197.67 | 2019-2023 | Balcoltra |
| Organon LLC | $188.42 | 2021-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $152.05 | 2019-2024 | |
| Coopersurgical, INC. | $148.17 | 2019-2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $139.84 | 2019-2022 | |
| Myriad Women'S Health, INC. | $134.35 | 2023 | Myrisk |
| Dysis Medical, INC. | $120.84 | 2020 | |
| Evofem Biosciences, INC. | $104.62 | 2020-2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $88.57 | 2020-2025 | Slynd |
| Axonics, INC. | $70.06 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $62.95 | 2023-2025 | Myfembree |
| Millicent US INC | $56.91 | 2020-2025 | Intrarosa, Femlyv |
| Allergan, INC. | $49.89 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $48.85 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $45.80 | 2019 | |
| Amag Pharmaceuticals, INC. | $45.46 | 2019-2021 | |
| Shield Therapeutics INC | $43.86 | 2023-2024 | Accrufer |
| Scynexis, INC. | $40.64 | 2022 | |
| Exact Sciences Corporation | $36.16 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $33.36 | 2025 | Wegovy |
| Coloplast Corp | $32.15 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $31.72 | 2019-2021 | |
| Baxter Healthcare | $30.82 | 2023 | |
| Lupin INC. | $30.44 | 2021 | |
| Channel Medsystems, INC. | $26.73 | 2023 | |
| Pfizer INC. | $26.19 | 2021 | |
| Meditrina | $24.74 | 2021-2023 | |
| Angiodynamics, INC. | $21.97 | 2019 | |
| Organogenesis INC. | $16.04 | 2024 | |
| Medicem INC. | $15.88 | 2021 | |
| Zyla Life Sciences, INC. | $15.43 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.38 | 2021 | |
| Davol INC. | $14.70 | 2023 | Arista Ah Flexitip |
| Supernus Pharmaceuticals, INC. | $14.19 | 2025 | Qelbree |
| Optumhealth Care Solutions, LLC | $13.86 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Gynesonics, INC. | $13.43 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amgen INC. | $12.83 | 2020 | |
| Agile Therapeutics, INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Astrid Mondaca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.